The American Hospital Association has called on federal regulators to intervene after Eli Lilly sent warning letters to 340B hospitals threatening to cut off discounted drug pricing unless they submit ...

The Trump administration is taking a targeted approach to reform a federal program that has long failed the patients and communities it was created to serve. Congress should allow that to move forward ...

The AHA again is asking the Health Resources and Services Administration to take action after Eli Lilly warned hospitals that ...

LYNN– At a recent State House briefing hosted by the Massachusetts Health & Hospital Association, healthcare leaders gathered to discuss the future of the 340B Drug Pricing Program, a critical funding ...

The American Hospital Association (AHA) writes to alert you to the latest development in connection with the growing number ...

Michigan's 340B Drug Pricing Program, meant to help vulnerable patients, is being misused by hospitals, impacting care access.

President Donald Trump has repeatedly vowed to “cut waste, fraud and abuse everywhere that we can find it.” Congressional ...

When South Dakota’s Rep. Dusty Johnson (R-SD) speaks about expanding the federal 340B Drug Pricing Program, he does so with ...

The 340B Drug Pricing Program must be reformed to better patient health and disincentivize institutional profit-seeking ...

While it may be hard to believe, there is one issue in Washington that meets the above criteria: fixing the 340B program.

AHA urges HRSA to axe 340B model that would cost hospitals over $1 billion annually and increase administrative burdens.

AbbVie is spearheading a new battle in pharma’s long-running fight to reform the federal government’s 340B drug discount program with a lawsuit that challenges the definition of what it means to be a ...